India’s Everest Organics starts making ingredient for Merck’s COVID-19 pill
2021-10-12
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidBENGALURU, Oct 12 (Reuters) – India’s Everest Organics Ltd (EVER.BO) said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co’s (MRK.N) experimental…Continue Reading